Asset Details

  • Description:
  • Outcome Measures Used in This StudyA, Total clinician’s score (TCS) by visit. B, Mean Skindex-29 scores by visit. C, Mean visual analog (VAS) scores for burning and/or pain by visit. D, Mean VAS scores for itching by visit. T0 indicates baseline; T1, after 1 month of therapy; T2, after 2 months of therapy; T3, at end of therapy; and F3, 3 months after the end of therapy. Error bars indicate the standard error of the mean.
  • License:
  • Rights Managed
  • Rights Holder:
  • JAMA
  • License Rights Holder:
  • Copyright 2014 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
  • Asset Type:
  • Image
  • Asset Subtype:
  • Chart/Graph
  • Image Orientation:
  • Landscape
  • Image Dimensions:
  • 1948 x 1427
  • Image File Size:
  • 30.6 KB
  • Creator:
  • Sarah Terras, Thilo Gambichler, Rose K. C. Moritz, Markus Stücker, Alexander Kreuter
  • Credit:
  • Terras, S., Gambichler, T., Moritz, R. K. C., Stücker, M., & Kreuter, A. (2014). UV-A1 Phototherapy vs Clobetasol Propionate, 0.05%, in the Treatment of Vulvar Lichen Sclerosus. JAMA Dermatology, 150(6), 621-627. https://doi.org/10.1001/jamadermatol.2013.7733.
  • Collection:
  • Keywords:
  • Restrictions:
  • Property Release:
  • No
  • Model Release:
  • No
  • Purchasable:
  • Yes
  • Sensitive Materials:
  • No
  • Article Authors:
  • Sarah Terras, Thilo Gambichler, Rose K. C. Moritz, Markus Stücker, Alexander Kreuter
  • Article Copyright Year:
  • Publication Volume:
  • 150
  • Publication Issue:
  • 6
  • Publication Date:
  • 06/11/2014
  • DOI:
  • https://doi.org/10.1001/jamadermatol.2013.7733

Click on image to enlarge

Would you like to download this asset? Tell us more and we can generate a quote, license and downloadable file.

Add to Cart